Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
Chunni Zhu, Tina Bilousova, Samantha Focht, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer’s Disease Brain Tissue Reveals Disease-Associated Signatures
Whitaker Cohn, Mikhail Melnik, Calvin Huang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 85
Extracellular vesicles in the treatment of neurological disorders
Samantha L. Reed, Andrew Escayg
Neurobiology of Disease (2021) Vol. 157, pp. 105445-105445
Open Access | Times Cited: 43
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
Kuo‐Hsuan Chang, Mei‐Ling Cheng, Hsiang-Yu Tang, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 395-395
Open Access | Times Cited: 28
Small but Mighty—Exosomes, Novel Intercellular Messengers in Neurodegeneration
Meena Kumari, Antje Anji
Biology (2022) Vol. 11, Iss. 3, pp. 413-413
Open Access | Times Cited: 28
A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities
Yun Pan, Jieying Li, P.T. Lin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases
Gavin McCluskey, Colette Donaghy, Karen Morrison, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1418-1418
Open Access | Times Cited: 21
Exosomes for the diagnosis and treatment of dementia
Hyeon Su Joo, Ha Yeong Jeon, Eun Be Hong, et al.
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 2, pp. 119-125
Closed Access | Times Cited: 11
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)
Tianzhen Hua, Huanxiao Shi, Mengmei Zhu, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 17
Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson’s Disease
David J. Rademacher
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1187-1187
Open Access | Times Cited: 10
An unraveled mystery: What's the role of brain sphingolipids in neurodegenerative and psychiatric disorders
Xintian Bie, Min Zhang, Qingyu Wang, et al.
Neurobiology of Disease (2025) Vol. 207, pp. 106852-106852
Open Access
Dynamic changes in the proximitome of neutral sphingomyelinase-2 (nSMase2) in TNFα stimulated Jurkat cells
Marie Schöl, Rebekka Schempp, Thomas Hennig, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Synucleinopathies: Intrinsic and Extrinsic Factors
Alma Karen Lomeli-Lepe, José Luis Castañeda‐Cabral, Silvia Josefina López‐Pérez
Cell Biochemistry and Biophysics (2023) Vol. 81, Iss. 3, pp. 427-442
Closed Access | Times Cited: 6
Potential roles of exosomes in the initiation and metastatic progression of lung cancer
Hongyuan Liang, Lingyun Zhang, Jian Rong
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115222-115222
Open Access | Times Cited: 4
Neuronal-enriched small extracellular vesicles trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s disease
Zhichun Chen, Wenming Li, Bo Meng, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110243-110243
Open Access | Times Cited: 1
Recommendation: Treatment of clinical long COVID encephalopathies with nasal administered mesenchymal stromal cell extracellular vesicles
Philip W. Askenase
Frontiers in Nanotechnology (2022) Vol. 4
Open Access | Times Cited: 4
Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
Chunni Zhu, Tina Bilousova, Samantha Focht, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Naive CD8br T Cell Affects Epilepsy through Partial Sphingomyelin Mediation: A Mendelian Randomization Study
Jinchao Wang, Kaiji LI, Yalong Gao, et al.
Research Square (Research Square) (2024)
Closed Access
Blockade of neutral sphingomyelinase 2 exerts antitumor effect on metastatic castration resistant prostate cancer cells and promotes tumor regression when combined with Enzalutamide
Shams Ge Shams, Dalal Dawud, Kasia Michalak, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 12, pp. 5697-5716
Closed Access
Alternative Macrophage Activation Requires Granulocyte-Derived Lipids
Tatyana Veremeyko, Anders Vik, Trond Vidar Hansen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Neuron-derived exosomes trigger a PD-L1-mediated broad suppression of T cells in Parkinson’s disease
Zhichun Chen, Chongchong Xu, Guanglu Li, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top